Search Within

Jennifer Jean Mueller

Formats
  1. Journal Article (84)
  2. Meeting Abstract (84)
  3. Review (7)
  4. Miscellaneous (4)
  5. Editorial (3)
  6. Book Section (2)
  7. Correspondence (2)
Groups
  1. GDMT, Surgery (186)
  2. Gynecology Disease Management Team (186)
  3. Surgery (186)
  4. Survivorship Research (186)
  5. Josie Robertson Surgery Center (126)
  6. GDMT, Pathology and Laboratory Medicine (93)

More Groups

People
  1. Nadeem Abu-Rustum (146)
  2. Mario Leitao (125)
  3. Yukio Sonoda (68)
  4. Britta Weigelt (54)
  5. Vance Broach (52)
  6. Kara Long Roche (49)

More People

Years
  1. 2025 (8)
  2. 2024 (31)
  3. 2023 (26)
  4. 2022 (25)
  5. 2021 (17)
  6. 2020 (37)

More Years

Publications
  1. Gynecologic Oncology (76)
  2. International Journal of Gynecological Cancer (49)
  3. Journal of Clinical Oncology (10)
  4. Gynecologic Oncology Reports (5)
  5. Annals of Surgical Oncology (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Elsevier Inc. (80)
  2. Lippincott Williams & Wilkins (53)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (7)
  5. Springer (7)
  6. American Association for Cancer Research (5)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Glaser, G.; McGree, M.; Eriksson, A. G. Z.; Pham, M.; Soliman, P.; Ataseven, B.; Alektiar, K.; Zamarin, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular and pathologic data can guide selection of endometrioid endometrial cancer patients for ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Liu, Y.; Ellenson, L.; Zhou, Q.; Leitao, M.; Abu-Rustum, N.; Weigelt, B.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and the utility of molecular classification in early stage endometrioid endometrial cancer
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; Weigelt, B.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular classification of endometrial carcinomas: A single-institution review
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Leitao, M.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
    Meeting Abstract

    Mueller, J.; Rios-Doria, E.; Park, K.; Broach, V.; Jewell, E.; Zivanovic, O.; Sonoda, Y.; Abu-Rustum, N.; Leitao, M.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes after recurrence of low-grade endometrial stromal sarcoma (LGESS)
    Meeting Abstract

    Miller, K.; Smith, E.; Sonoda, Y.; Mueller, J.; Alektiar, A.; Makker, V.; Hensley, M.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Risk stratification of stage I grade 3 endometrioid endometrial carcinoma
    Meeting Abstract

    Zammarrelli, W.; Kim, S.; Paula, A. D. C.; Rios-Doria, E.; Zhou, Q.; Alektiar, K.; Aghajanian, C.; Makker, V.; Leitao, M.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study
    Journal Article

    Kurnit, K. C.; Nobre, S. P.; Fellman, B. M.; Iglesias, D. A.; Lindemann, K.; Jhingran, A.; Eriksson, A. G. Z.; Ataseven, B.; Glaser, G. E.; Mueller, J. J.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
    Journal Article

    Ehmann, S.; Sassine, D.; Straubhar, A. M.; Praiss, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Boroujeni, A. M.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save